Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
7.59
-0.33 (-4.23%)
Oct 14, 2025, 3:27 PM EDT - Market open
Lyra Therapeutics Market Cap
Lyra Therapeutics has a market cap or net worth of $12.47 million as of October 14, 2025. Its market cap has decreased by -21.06% in one year.
Market Cap
12.47M
Enterprise Value
15.72M
1-Year Change
-21.06%
Ranking
Category
Stock Price
$7.59
Market Cap Chart
Since May 1, 2020, Lyra Therapeutics's market cap has decreased from $230.14M to $12.47M, a decrease of -94.58%. That is a compound annual growth rate of -41.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2025 | 13.02M | -3.60% |
| Dec 31, 2024 | 13.51M | -95.09% |
| Dec 29, 2023 | 275.43M | 175.60% |
| Dec 30, 2022 | 99.94M | 76.26% |
| Dec 31, 2021 | 56.70M | -61.52% |
| Dec 31, 2020 | 147.37M | -35.97% |
| May 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |